Home LiteratureArticle Details
PMID: 15194769 Published · ppublish English Journal Article

The two major human metapneumovirus genetic lineages are highly related antigenically, and the fusion (F) protein is a major contributor to this antigenic relatedness.

Journal of virology ·Vol. 78 ·No. 13 ·2004-07-00 ·Pages 6927-37

Skiadopoulos MH, Biacchesi S, Buchholz UJ, Riggs JM, Surman SR, Amaro-Carambot E, McAuliffe JM, Elkins WR, St Claire M, Collins PL, Murphy BR

Abstract

The growth properties and antigenic relatedness of the CAN98-75 (CAN75) and the CAN97-83 (CAN83) human metapneumovirus (HMPV) strains, which represent the two distinct HMPV genetic lineages and exhibit 5 and 63% amino acid divergence in the fusion (F) and attachment (G) proteins, respectively, were investigated in vitro and in rodents and nonhuman primates. Both strains replicated to high titers (> or =6.0 log(10)) in the upper respiratory tract of hamsters and to moderate titers (> or =3.6 log(10)) in the lower respiratory tract. The two lineages exhibited 48% antigenic relatedness based on reciprocal cross-neutralization assay with postinfection hamster sera, and infection with each strain provided a high level of resistance to reinfection with the homologous or heterologous strain. Hamsters immunized with a recombinant human parainfluenza virus type 1 expressing the fusion F protein of the CAN83 strain developed a serum antibody response that efficiently neutralized virus from both lineages and were protected from challenge with either HMPV strain. This result indicates that the HMPV F protein is a major antigenic determinant that mediates extensive cross-lineage neutralization and protection. Both HMPV strains replicated to low titers in the upper and lower respiratory tracts of rhesus macaques but induced high levels of HMPV-neutralizing antibodies in serum effective against both lineages. The level of HMPV replication in chimpanzees was moderately higher, and infected animals developed mild colds. HMPV replicated the most efficiently in the respiratory tracts of African green monkeys, and the infected animals developed a high level of HMPV serum-neutralizing antibodies (1:500 to 1:1,000) effective against both lineages. Reciprocal cross-neutralization assays in which postinfection sera from all three primate species were used indicated that CAN75 and CAN83 are 64 to 99% related antigenically. HMPV-infected chimpanzees and African green monkeys were highly protected from challenge with the heterologous HMPV strain. Taken together, the results from hamsters and nonhuman primates support the conclusion that the two HMPV genetic lineages are highly related antigenically and are not distinct antigenic subtypes or subgroups as defined by reciprocal cross-neutralization in vitro.

MeSH Terms
Animals Antibodies, Viral/blood,immunology Antigenic Variation Base Sequence Cell Line Cricetinae Cross Reactions Disease Models, Animal Humans Metapneumovirus/genetics,immunology,physiology Molecular Sequence Data Neutralization Tests Pan troglodytes Parainfluenza Virus 1, Human/genetics,immunology Paramyxoviridae Infections/virology Respiratory System/virology Viral Fusion Proteins/chemistry,genetics,immunology Virus Replication
Chemicals
Antibodies, Viral F protein, parainfluenza virus 1 Viral Fusion Proteins
Authors & Affiliations
11 authors, click to expand affiliations / ORCID
Skiadopoulos Mario H
Respiratory Viruses Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Disease, National Institutes of Health, Building 50, Room 6511, 50 South Dr., MSC 8007, Bethesda, MD 20892-8007, USA. mskiadopoulos@niaid.nih.gov
Biacchesi Stéphane
Buchholz Ursula J
Riggs Jeffrey M
Surman Sonja R
Amaro-Carambot Emerito
McAuliffe Josephine M
Elkins William R
St Claire Marisa
Collins Peter L
Murphy Brian R
References (40)
40 references, click to expand
  1. Characterization of human metapneumoviruses isolated from patients in North America.
    J Infect Dis. 2002 Jun 1;185(11):1660-3 PMID: 12023774
  2. ANTIGENIC VARIATION AMONG NEWLY ISOLATED STRAINS OF PARAINFLUENZA TYPE 4 VIRUS.
    Am J Hyg. 1964 May;79:357-64 PMID: 14159955
  3. The genome length of human parainfluenza virus type 2 follows the rule of six, and recombinant viruses recovered from non-polyhexameric-length antigenomic cDNAs contain a biased distribution of correcting mutations.
    J Virol. 2003 Jan;77(1):270-9 PMID: 12477832
  4. Human metapneumovirus in the community.
    Lancet. 2003 Mar 15;361(9361):890-1 PMID: 12648965
  5. Sequence analysis of the N, P, M and F genes of Canadian human metapneumovirus strains.
    Virus Res. 2003 May;93(1):51-62 PMID: 12727342
  6. Long nucleotide insertions between the HN and L protein coding regions of human parainfluenza virus type 3 yield viruses with temperature-sensitive and attenuation phenotypes.
    Virology. 2000 Jun 20;272(1):225-34 PMID: 10873765
  7. Bovine parainfluenza virus type 3 (BPIV3) fusion and hemagglutinin-neuraminidase glycoproteins make an important contribution to the restricted replication of BPIV3 in primates.
    J Virol. 2000 Oct;74(19):8922-9 PMID: 10982335
  8. N-glycosylation contributes to the limited cross-reactivity between hemagglutinin neuraminidase proteins of human parainfluenza virus type 4A and 4B.
    Med Microbiol Immunol. 2000 Sep;189(1):1-6 PMID: 11034551
  9. A newly discovered human pneumovirus isolated from young children with respiratory tract disease.
    Nat Med. 2001 Jun;7(6):719-24 PMID: 11385510
  10. A single amino acid substitution in the viral polymerase creates a temperature-sensitive and attenuated recombinant bovine parainfluenza virus type 3.
    Virology. 2001 Sep 30;288(2):342-50 PMID: 11601905
  11. Sequence analysis of the Washington/1964 strain of human parainfluenza virus type 1 (HPIV1) and recovery and characterization of wild-type recombinant HPIV1 produced by reverse genetics.
    Virus Genes. 2002;24(1):77-92 PMID: 11928991
  12. Children with respiratory disease associated with metapneumovirus in Hong Kong.
    Emerg Infect Dis. 2003 Jun;9(6):628-33 PMID: 12781000
  13. Human metapneumovirus infections in hospitalized children.
    Emerg Infect Dis. 2003 Jun;9(6):634-40 PMID: 12781001
  14. Effects of human metapneumovirus and respiratory syncytial virus antigen insertion in two 3' proximal genome positions of bovine/human parainfluenza virus type 3 on virus replication and immunogenicity.
    J Virol. 2003 Oct;77(20):10819-28 PMID: 14512532
  15. Genetic diversity between human metapneumovirus subgroups.
    Virology. 2003 Oct 10;315(1):1-9 PMID: 14592754
  16. Chemokine regulation of inflammation during acute viral infection.
    Curr Opin Allergy Clin Immunol. 2003 Dec;3(6):467-73 PMID: 14612671
  17. Clinical impact and diagnosis of human metapneumovirus infection.
    Pediatr Infect Dis J. 2004 Jan;23(1 Suppl):S25-32 PMID: 14730267
  18. Recovery of human metapneumovirus from cDNA: optimization of growth in vitro and expression of additional genes.
    Virology. 2004 Apr 10;321(2):247-59 PMID: 15051385
  19. An antigenic analysis of respiratory syncytial virus isolates by a plaque reduction neutralization test.
    Am J Epidemiol. 1966 Mar;83(2):299-313 PMID: 5933417
  20. Experimental respiratory syncytial virus infection of four species of primates.
    J Med Virol. 1977;1(3):157-62 PMID: 416176
  21. A simple method for increased recovery of purified paramyxovirus virions.
    J Virol Methods. 1985 Oct;12(1-2):179-82 PMID: 3001119
  22. The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: extensive sequence divergence between antigenically related proteins.
    Proc Natl Acad Sci U S A. 1987 Aug;84(16):5625-9 PMID: 2441388
  23. Antigenic relatedness between glycoproteins of human respiratory syncytial virus subgroups A and B: evaluation of the contributions of F and G glycoproteins to immunity.
    J Virol. 1987 Oct;61(10):3163-6 PMID: 3305988
  24. Strain-specific serum antibody responses in infants undergoing primary infection with respiratory syncytial virus.
    J Infect Dis. 1988 Apr;157(4):640-7 PMID: 3346563
  25. Attenuation of bovine parainfluenza virus type 3 in nonhuman primates and its ability to confer immunity to human parainfluenza virus type 3 challenge.
    J Infect Dis. 1988 Apr;157(4):655-62 PMID: 2831282
  26. Isolation and characterization of monoclonal antibodies to human parainfluenza virus type 4 and their use in revealing antigenic relation between subtypes 4A and 4B.
    Virology. 1989 Jul;171(1):28-37 PMID: 2472703
  27. Immunosuppression of the antibody response to respiratory syncytial virus (RSV) by pre-existing serum antibodies: partial prevention by topical infection of the respiratory tract with vaccinia virus-RSV recombinants.
    J Gen Virol. 1989 Aug;70 ( Pt 8):2185-90 PMID: 2671259
  28. Molecular cloning and sequence analysis of human parainfluenza type 4A virus HN gene: its irregularities on structure and activities.
    Virology. 1990 Mar;175(1):307-12 PMID: 2155512
  29. Respiratory syncytial virus (RSV) F, G, M2 (22K), and N proteins each induce resistance to RSV challenge, but resistance induced by M2 and N proteins is relatively short-lived.
    J Virol. 1991 Mar;65(3):1634-7 PMID: 1995956
  30. Cold-passaged human parainfluenza type 3 viruses contain ts and non-ts mutations leading to attenuation in rhesus monkeys.
    Virus Res. 1992 Mar;22(3):173-84 PMID: 1320790
  31. A comparison in chimpanzees of the immunogenicity and efficacy of live attenuated respiratory syncytial virus (RSV) temperature-sensitive mutant vaccines and vaccinia virus recombinants that express the surface glycoproteins of RSV.
    Vaccine. 1993 Nov;11(14):1395-404 PMID: 8310760
  32. Satisfactorily attenuated and protective mutants derived from a partially attenuated cold-passaged respiratory syncytial virus mutant by introduction of additional attenuating mutations during chemical mutagenesis.
    Vaccine. 1994 Jun;12(8):691-9 PMID: 8091846
  33. Impairment of multicycle influenza virus growth in Vero (WHO) cells by loss of trypsin activity.
    J Virol. 1995 Apr;69(4):2700-3 PMID: 7884927
  34. Sequence analyses of human parainfluenza virus type 4A and type 4B fusion proteins.
    J Gen Virol. 1995 Dec;76 ( Pt 12):3205-10 PMID: 8847531
  35. The bovine papillomavirus type 1 E2 transactivator and repressor proteins use different nuclear localization signals.
    J Virol. 1996 Feb;70(2):1117-24 PMID: 8551571
  36. Paramyxovirus RNA synthesis and the requirement for hexamer genome length: the rule of six revisited.
    J Virol. 1998 Feb;72(2):891-9 PMID: 9444980
  37. Identification of mutations contributing to the temperature-sensitive, cold-adapted, and attenuation phenotypes of the live-attenuated cold-passage 45 (cp45) human parainfluenza virus 3 candidate vaccine.
    J Virol. 1999 Feb;73(2):1374-81 PMID: 9882342
  38. Comparison of the immunogenicity and efficacy of a replication-defective vaccinia virus expressing antigens of human parainfluenza virus type 3 (HPIV3) with those of a live attenuated HPIV3 vaccine candidate in rhesus monkeys passively immunized with PIV3 antibodies.
    J Infect Dis. 1999 Jun;179(6):1345-51 PMID: 10228053
  39. Persistent antigenic variation of influenza A viruses after incomplete neutralization in ovo with heterologous immune serum.
    J Exp Med. 1950 Nov 1;92(5):441-62 PMID: 14778924
  40. Analysis of the genomic sequence of a human metapneumovirus.
    Virology. 2002 Mar 30;295(1):119-32 PMID: 12033771
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
2004-07-00
Pages
6927-37
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC421687
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com